Department of Dermatology, Ludwig-Maximilians-Universität, Frauenlobstr. 9-11, 80337 Muenchen, Germany.
Drug Discov Today. 2011 Feb;16(3-4):132-9. doi: 10.1016/j.drudis.2010.12.001. Epub 2010 Dec 10.
Modern tissue culture technology has made it possible to generate human skin equivalents that represent either epidermis or epidermis plus dermis (full-thickness skin) in vitro. Commercially available skin equivalents and in-house models are used for safety analysis of cosmetics and toxicity screening of various pharmaceutical compounds. Recently, tissue culture technology has also been used to develop in vitro models of skin disease, in particular to promote cutaneous drug research while sparing experimental animals. The spectrum of model diseases available covers a range from inflammatory disease to cancer. It has, thus, been possible to gain more insight into the role of active pharmaceutical ingredients of various dermatologically relevant drug classes as well as conventional and innovative formulations.
现代组织培养技术已经使得体外生成代表表皮或表皮加真皮(全层皮肤)的人皮肤等效物成为可能。商业上可获得的皮肤等效物和内部模型用于化妆品的安全性分析和各种药物化合物的毒性筛选。最近,组织培养技术也被用于开发皮肤疾病的体外模型,特别是在不使用实验动物的情况下促进皮肤药物研究。可用的模型疾病范围涵盖从炎症性疾病到癌症。因此,人们可以更深入地了解各种皮肤科相关药物类别的活性药物成分以及常规和创新制剂的作用。